Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (180)	3/10/2002 3:16:50 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 631

[Ice List] That's wonderful! Lot's of "scurrying off to Medline" stuff there. >> not completely up-to-date << You can certainly say that! This one is particularly hilarious........ VIMRxyn Nexell Therapeutics Light sensitizer phase I & II Go to the health food store, buy some hypericin. This was the classical Rosenwald company and clinical effort, IMO. Make money, even if there's no real (IMO) intent to make a medicine. If your psoriasis doesn't go away, maybe you won't be depressed. So, we have a bunch of giggly psoriasis patients in Thailand with sun burns. Scum bags. >> I have done some re-editing and re-sorting to make the information more readable (hopefully). << This list is GREAT. We should chip away at it, and also add gently to it when appropriate. I'd suggest that all posts referring to it start with the header "[Ice List]".

To: Icebrg who wrote (180)	3/10/2002 8:48:48 PM
From: software salesperson	Read Replies (1) \| Respond to of 631

ice list this list is almost identical to one published in the npf bulletin(not yet online) in nov/dec 2001. the one omission is: isis 104838 antisense inhibitor of tnf;topical phase 2 sales

To: Icebrg who wrote (180)	4/1/2002 11:40:00 AM
From: Icebrg	Read Replies (2) \| Respond to of 631

Eric Ende @ Bank of America reports from AAD (February 25, 2002). Ice bofasecurities.com

To: Icebrg who wrote (180)	3/7/2005 7:02:40 PM
From: software salesperson	Read Replies (1) \| Respond to of 631

source: national psoriasis foundation march 2005 updated table.i can't figure out how to make it more readable. thankfully, being able to use technology is not a prerequisite for selling it. sales Treatments in development for psoriasis and/or psoriatic arthritis Amevive (alefacept) Biogen Idec systemic biologic reduces T lymphocytes (CD11) phase II for psoriatic arthritis Avandia (rosiglitazone maleate) GlaxoSmithKline oral antidiabetic agent phase III for psoriasis ATL1101 Antisense Therapeutics, LTD. IGF-1 receptor blocking cream pre-clinical for psoriasis Becocalcidiol QUATRx Pharmaceuticals Co. topical vitamin D derivative phase II for psoriasis Bimosiamose (bimosiamose microemulsion) Revotar Biopharmaceuticals AG endothelin A receptor antagonist phase II for psoriasis CRx-140 CombinatoRx combination of loratidine and cyclosporine, an antihistamine and an immunosuppressant phase II for psoriasis Ecalcidene Barrier Therapeutics vitamin D(3) derivative pre-clinical for psoriasis Elidel (pimecrolimus) Novartis Pharmaceuticals Corp. oral anti-inflammatory phase II for psoriasis Enbrel (etanercept) Amgen & Wyeth TNF-alpha inhibitor phase IV for pediatric psoriasis Humira (adalimumab) Abbott Immunology monoclonal antibody filed for approval 12/04 for psoriatic arthritis; phase II for psoriasis IR502 Immune Response Corp. causes immune system to shut down activated T cells phase II complete for psoriasis ISA247 Isotechnika systemic immunosuppressant phase II complete; phase III in Canada for psoriasis Novasome A/B (PTH (1-34)) IGI regulates epidermal growth and differentiation phase I complete for psoriasis Onercept (r-TBP-1) Serono, S.A. TNF-alpha inhibitor phase III for psoriasis; phase II complete for psoriatic arthritis Paxceed (paclitaxel) Angiotech Pharmaceuticals topical angiogenesis inhibitor phase II complete for psoriasis Panretin (alitretinoin) (oral) Ligand Pharmaceuticals vitamin A derivative phase II complete for psoriasis Panretin (alitretinoin) (topical) Ligand Pharmaceuticals topical gel, vitamin A derivative phase IV complete for psoriasis PhotoPoint Miravant Medical Technologies photodynamic therapy for plaque psoriasis phase II for psoriasis Psoraxine (AS210) Astralis, LTD. injectable immuno-therapeutic agent phase II for psoriasis Rambazole Barrier Therapeutics topical retinoic acid metabolism blocking agents phase I for psoriasis Raptiva (efalizumab) Genentech, Inc. blocks activation and migration of T cells phase IV for safety, pregnancy for psoriasis Remicade (infliximab) Centocor, Inc. TNF-alpha inhibitor filed for approval 12/04 for psoriatic arthritis; phase III for psoriasis Oral tazarotene Allergan, Inc. oral version of topical vitamin A derivative phase III complete; non-approvable letter September 2004 for psoriasis Tadekinig-alpha (r-IL-18 BP) Serono, S.A. Il-18 inhibitor phase II for psoriasis Vitaxin Medimmune monoclonal antibody phase II halted for psoriasis VX-765 Vertex Pharmaceuticals cytokine inhibitor phase II for psoriasis Xantryl Provectus Pharmaceuticals UV light-activated topical phase I complete for psoriasis XP-828L Advitech bioactive products derived from milk proteins DSHEA clinical trial for psoriasis(Dietary Supplement Health Education Act) Zenapax (daclizumab) Protein Design Labs SMART Anti-Tac Antibody phase II complete for psoriasis